Skip to content
FacebookTwitterLinkedIn
VxP Pharma Logo VxP Pharma Logo VxP Pharma Logo

Contact us or call 317.759.2299

  • Home
  • About
    • The Company
    • The Management Team
    • Ask Our Experts
    • Events
    • Careers
  • Services
    • Analytical & Bioanalytical
      • Bioanalytical Testing
      • Material Characterization
      • Particle Size Determination
    • Formulation Development & Clinical Trial Materials (CTM)
      • Different Dosage Forms & Clinical Supplies
        • Capsules: Powder, Granule, Liquid Filling
        • Liquids: Solutions, Suspensions & Emulsions
        • Powders: Powder in a Bottle
        • Parenteral and Lyophillized Clinical Trial Materials
        • Semi Solids Manufacturing: Creams, Ointments Gels and Lotions
        • Solid Dispersions
        • Tablets Controlled Release & Manufacturing of Tablets
        • Transdermal
      • Dissolution Testing
      • Generic Drug Manufacturing & Bioavailability Enhancement
      • Highly Potent and Cytotoxic Compounds
      • IND/First-in-Man Enabling Studies
      • Phase I, II, III CTM & Commercial Scale (1kg up to 400kg)
      • Sustained Release Formulations & Complex Formulations
      • Working with Insoluble Compounds
    • Generic & Commercial Drug Manufacturing Services
      • Capsules: Powder, Granule, Liquid Filling
      • Liquids: Solutions, Suspensions & Emulsions
      • Parenteral & Syringe Manufacturing
      • Powders: Powder in a Bottle
      • Semi Solids Manufacturing: Creams, Ointments Gels and Lotions
      • Solid Dispersions
      • Tablets Controlled Release & Manufacturing of Tablets
      • Transdermal
    • Lyophilization
      • GLP Tox Materials
      • Lyophilization Cycle Development & Optimization
    • Parenteral & Syringe Manufacturing
      • Highly Potent and Cytotoxic Compounds
      • Parenteral Formulations and Fill/Finish
    • Preclinical
      • ADME, DMPK (InVivo/InVitro)
        • ADME Studies
        • In Vitro Services
        • In Vivo Pharmacology Services
      • Medical Device Biocompatibility
      • Pharmacology
        • Cardiovascular
        • CNS
        • GI
        • Inflammation
        • Oncology and Xenograph
        • Ophthalmic In-Vitro / In-Vivo Testing
        • Pain
      • Pharmaceutical Toxicology
        • Acute/Sub Chronic/Chronic
        • Dermal
        • Development & Reproductive Tox (DART)
        • Dose Range Finding (DRF)
        • Histopathology
        • Pathology/Clinical Pathology
    • Preformulation & Solid State Chemistry
      • Amorphous Solid Dispersions
      • API Crystallization and Optimization
      • Cocrystals
      • Early Tox Formulations
      • Flowability
      • Polymorphism
      • Salt Selection
      • Solution-State Stability
      • Solid-State Stability
  • Resources
  • Blog
  • Contact
  • Home
  • About
    • The Company
    • The Management Team
    • Ask Our Experts
    • Events
    • Careers
  • Services
    • Analytical & Bioanalytical
      • Bioanalytical Testing
      • Material Characterization
      • Particle Size Determination
    • Formulation Development & Clinical Trial Materials (CTM)
      • Different Dosage Forms & Clinical Supplies
        • Capsules: Powder, Granule, Liquid Filling
        • Liquids: Solutions, Suspensions & Emulsions
        • Powders: Powder in a Bottle
        • Parenteral and Lyophillized Clinical Trial Materials
        • Semi Solids Manufacturing: Creams, Ointments Gels and Lotions
        • Solid Dispersions
        • Tablets Controlled Release & Manufacturing of Tablets
        • Transdermal
      • Dissolution Testing
      • Generic Drug Manufacturing & Bioavailability Enhancement
      • Highly Potent and Cytotoxic Compounds
      • IND/First-in-Man Enabling Studies
      • Phase I, II, III CTM & Commercial Scale (1kg up to 400kg)
      • Sustained Release Formulations & Complex Formulations
      • Working with Insoluble Compounds
    • Generic & Commercial Drug Manufacturing Services
      • Capsules: Powder, Granule, Liquid Filling
      • Liquids: Solutions, Suspensions & Emulsions
      • Parenteral & Syringe Manufacturing
      • Powders: Powder in a Bottle
      • Semi Solids Manufacturing: Creams, Ointments Gels and Lotions
      • Solid Dispersions
      • Tablets Controlled Release & Manufacturing of Tablets
      • Transdermal
    • Lyophilization
      • GLP Tox Materials
      • Lyophilization Cycle Development & Optimization
    • Parenteral & Syringe Manufacturing
      • Highly Potent and Cytotoxic Compounds
      • Parenteral Formulations and Fill/Finish
    • Preclinical
      • ADME, DMPK (InVivo/InVitro)
        • ADME Studies
        • In Vitro Services
        • In Vivo Pharmacology Services
      • Medical Device Biocompatibility
      • Pharmacology
        • Cardiovascular
        • CNS
        • GI
        • Inflammation
        • Oncology and Xenograph
        • Ophthalmic In-Vitro / In-Vivo Testing
        • Pain
      • Pharmaceutical Toxicology
        • Acute/Sub Chronic/Chronic
        • Dermal
        • Development & Reproductive Tox (DART)
        • Dose Range Finding (DRF)
        • Histopathology
        • Pathology/Clinical Pathology
    • Preformulation & Solid State Chemistry
      • Amorphous Solid Dispersions
      • API Crystallization and Optimization
      • Cocrystals
      • Early Tox Formulations
      • Flowability
      • Polymorphism
      • Salt Selection
      • Solution-State Stability
      • Solid-State Stability
  • Resources
  • Blog
  • Contact
  • Home
  • About
    • The Company
    • The Management Team
    • Ask Our Experts
    • Events
    • Careers
  • Services
    • Analytical & Bioanalytical
      • Bioanalytical Testing
      • Material Characterization
      • Particle Size Determination
    • Formulation Development & Clinical Trial Materials (CTM)
      • Different Dosage Forms & Clinical Supplies
        • Capsules: Powder, Granule, Liquid Filling
        • Liquids: Solutions, Suspensions & Emulsions
        • Powders: Powder in a Bottle
        • Parenteral and Lyophillized Clinical Trial Materials
        • Semi Solids Manufacturing: Creams, Ointments Gels and Lotions
        • Solid Dispersions
        • Tablets Controlled Release & Manufacturing of Tablets
        • Transdermal
      • Dissolution Testing
      • Generic Drug Manufacturing & Bioavailability Enhancement
      • Highly Potent and Cytotoxic Compounds
      • IND/First-in-Man Enabling Studies
      • Phase I, II, III CTM & Commercial Scale (1kg up to 400kg)
      • Sustained Release Formulations & Complex Formulations
      • Working with Insoluble Compounds
    • Generic & Commercial Drug Manufacturing Services
      • Capsules: Powder, Granule, Liquid Filling
      • Liquids: Solutions, Suspensions & Emulsions
      • Parenteral & Syringe Manufacturing
      • Powders: Powder in a Bottle
      • Semi Solids Manufacturing: Creams, Ointments Gels and Lotions
      • Solid Dispersions
      • Tablets Controlled Release & Manufacturing of Tablets
      • Transdermal
    • Lyophilization
      • GLP Tox Materials
      • Lyophilization Cycle Development & Optimization
    • Parenteral & Syringe Manufacturing
      • Highly Potent and Cytotoxic Compounds
      • Parenteral Formulations and Fill/Finish
    • Preclinical
      • ADME, DMPK (InVivo/InVitro)
        • ADME Studies
        • In Vitro Services
        • In Vivo Pharmacology Services
      • Medical Device Biocompatibility
      • Pharmacology
        • Cardiovascular
        • CNS
        • GI
        • Inflammation
        • Oncology and Xenograph
        • Ophthalmic In-Vitro / In-Vivo Testing
        • Pain
      • Pharmaceutical Toxicology
        • Acute/Sub Chronic/Chronic
        • Dermal
        • Development & Reproductive Tox (DART)
        • Dose Range Finding (DRF)
        • Histopathology
        • Pathology/Clinical Pathology
    • Preformulation & Solid State Chemistry
      • Amorphous Solid Dispersions
      • API Crystallization and Optimization
      • Cocrystals
      • Early Tox Formulations
      • Flowability
      • Polymorphism
      • Salt Selection
      • Solution-State Stability
      • Solid-State Stability
  • Resources
  • Blog
  • Contact

Resources

ResourcesSonya Iverson2018-01-13T22:30:56+00:00

Preclinical

Preclinical SD

GLP Extractables and Leachables Flyer

Preformulation and Solid State Chemistry

VxP SMART Services SD

VxP Solid State Chemistry SD

Formulation Development and CTM

cGMP HME Services Flyer

cGMP Spray Drying Services Flyer

VxP Formulation Development and CTM SD

VxP Transdermal Services SD

VxP Lyophilization Services

Sterile Development and Manufacturing Services SD

Lyophilization Flyer

Parenteral and Syringe Manufacturing

VxP Sterile Development and Manufacturing Services SD

Generic and Commercial Drug Manufacturing Services

VxP Commercial Services SD

Press Releases, VxP Articles, and White Papers

VxP Corporate Presentation
Factors to Consider…
Five Crucial Concerns…
Crystal Pharmatech Press Release

VxP Pharma

Purdue Research Park
5225 Exploration Drive
Indianapolis, IN 46241

Meet with us

Events

CONTACT US

VxP Pharma offers a full range of contract development and manufacturing services, as well as technical and regulatory support.

Our experts can answer your questions.

Contact Us
Copyright 2018 VxP Pharma | Designed by in vivo Designs
FacebookTwitterLinkedIn
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy